This webpage is intended for European users.
Availability of products and services may vary by region, and some items may not be offered outside of Europe.
WHY CORELINE
We have already made all the preparations for Lung Cancer Screening in Germany.
01HANSE Study for 2 years
02Support Joint Assessment
1. Automated Nodule Detection
2. Longitudinal Analysis
3. LCS Dedicated Viewer
4. Delivering Comprehensive Analysis Results
1. Interoperability
• Support independent 2nd reading.
• Facilitate joint assessment between users.
2. Worklist Management
• Manage multiple centers in a single worklist.
• Allow efficient organization and filtering.
3. Pseudonymization
• Protect sensitive patient information (PHI)
with GDPR-compliant pseudonymization.
4. Process Automation
• Streamline workflows with flexible customization.
• Automate time-consuming manual tasks.
Advancing Lung Cancer Screening with German Partners.
We chose
CorelineSoft's AVIEW LCS PLUS
because it allows us
to extract the biomarkers
we need for our HANSE study
in a fully automated workflow.
In addition to nodule detection,
we analyze lung nodules
and lung cancer by volume.
Coronary calcium scores and emphysema
can be analyzed fully automatically.
Jens Vogel-Claussen
HANSE PI, German Lung Cancer Screening Hanse,
Professor, University of Hannover, Germany
Official Solution for
Nationwide Lung Cancer Screening Program in
South Korea, Germany, Italy, and Intra-Europe Partnerships
South Korea, 5 European countries, Italy, Germany Selected as the official solution
for the Lung Cancer Screening Project
EU
4ITLR
European Lung Cancer Screening Trial
Germany
HANSE
Germany Lung Cancer Screening Trial
ITALY
RISP
Italian Lung Screening Project
KOREA
K-LUCAS
Korean Lung Cancer Screening Trial
Detect Lung Nodules, COPD, and CAC
from One Scan using AI.
Clinical Webinar
Lung Cancer Screening in Germany and the Role of AI software
From Screening to treatment
Webinar agenda
1
Prof. Dr. med. Jens Vogel-Claussen, Hannover Medical School
2
Dr. Benjamin-Alexander Bollmann,
MHH Department of respiratory medicine and infectious diseases
3
Dr. Patrick Zardo, MHH Thoracic surgery